SCHEMBL6020596

SCHEMBL6020596

N#CCNC(=O)C(Cc1ccc2ccccc2c1)NC(=O)NCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CTSB P07858 12/20 0.70
CTSS P25774 11/20 0.70
CTSL P07711 10/20 0.70
CTSK P43235 6/20 0.69
PSMB1 P20618 1/20 0.60
PSMB5 P28074 1/20 0.60
PSMB2 P49721 1/20 0.60
FCER2 P06734 1/20 0.58
MMP2 P08253 1/20 0.56
MMP9 P14780 1/20 0.56
MMP8 P22894 1/20 0.56
ANPEP P15144 1/20 0.56
CTSV O60911 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021162 0.95 CTSB (0.65) CTSBCTSSCTSLCTSKPSMB1
SCHEMBL6021148 0.92 CTSB (0.65) CTSBCTSSCTSLCTSKPSMB1
SCHEMBL6020170 0.90 CTSS (0.58) CTSBCTSSCTSLCTSKPSMB1
SCHEMBL6447794 0.89 CTSB (0.68) CTSBCTSSCTSLCTSKCTSV
SCHEMBL6020371 0.88 CTSS (0.73) CTSBCTSSCTSLCTSKPSMB5
SCHEMBL6020107 0.88 CTSB (0.62) CTSBCTSSCTSLCTSKPSMB1
SCHEMBL6021309 0.86 CTSS (0.74) CTSBCTSSCTSLCTSKCTSV
SCHEMBL6019462 0.86 CTSB (0.54) CTSBCTSSCTSLCTSKPSMB1
SCHEMBL6021043 0.85 ATM (0.69) CTSBCTSSCTSLCTSKANPEP
SCHEMBL6020441 0.85 CTSL (0.71) CTSBCTSSCTSLCTSKPSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP claimed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO claimed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP disclosed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO disclosed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 CTSB 2514/4885CTSS 2720/4885CTSL 2274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.